Literature DB >> 11515587

Studies on anthracenes. 1. Human telomerase inhibition and lipid peroxidation of 9-acyloxy 1,5-dichloroanthracene derivatives.

H S Huang1, J M Hwang, Y M Jen, J J Lin, K Y Lee, C H Shi, H C Hsu.   

Abstract

The synthetically useful approaches to 9-acyloxy 1,5-dichloroanthracene derivatives are reported. The system selectively reduces the carbonyl group flanked by the peri substituents of the anthracenediones to give the corresponding 1,5-dichloro-9(10H)-anthracenone. Simple regioselective acylation of anthracenone is applied with appropriate acyl chlorides in CH2Cl2 with catalytic amount of pyridine to give the novel 9-acyloxy 1,5-dichloroanthracene derivatives. Considerable interest has developed in the mechanism of how anthracenone achieves this desirable selectivity. In an attempt to understand the mechanism of this reaction, solid-state structures of anthracene derivatives have been obtained. In addition, the inhibition of lipid peroxidation in model membranes was determined as was their ability to inhibit the telomere-addition function of the human telomerase enzyme together with their inhibition of the Taq polymerase enzyme. In contrast to (+)-alpha-tocopherol, 3b, 3c, 3d, 3g, and 3i do not enhance lipid peroxidation in model membranes. Implications for 9-acyloxy 1,5-dichloroanthracene analogues as potential anticancer agents are discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11515587     DOI: 10.1248/cpb.49.969

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  2 in total

1.  Enantioselective Michael reaction of anthrone catalyzed by chiral tetraoxacalix[2]arene[2]triazine derivatives.

Authors:  Hayriye Nevin Genc
Journal:  RSC Adv       Date:  2019-07-05       Impact factor: 4.036

2.  Expanding the scope of Metal-Free enantioselective allylic substitutions: Anthrones.

Authors:  Victor Ceban; Jiří Tauchman; Marta Meazza; Greg Gallagher; Mark E Light; Ivana Gergelitsová; Jan Veselý; Ramon Rios
Journal:  Sci Rep       Date:  2015-11-23       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.